QLT Inc. (QLTI)
-NasdaqGS 8.43 
0.32(3.95%) Jun 17, 4:00PM EDT
| Prev Close: | 8.11 |
|---|
| Open: | 8.24 |
|---|
| Bid: | 6.78 x 1000 |
|---|
| Ask: | 9.29 x 300 |
|---|
| 1y Target Est: | 10.08 |
|---|
| Beta: | 0.1 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 8.13 - 8.45 |
|---|
| 52wk Range: | 6.33 - 9.10 |
|---|
| Volume: | 179,631 |
|---|
| Avg Vol (3m): | 100,853 |
|---|
| Market Cap: | 426.04M |
|---|
| P/E (ttm): | 8.59 |
|---|
| EPS (ttm): | 0.98 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- QLT Inc. shareholders approve $200M special distributiontheflyonthewall.com(Fri, Jun 14)
- QLT Announces Shareholder Approval of US$200 Million Special Cash Distribution to Shareholders and Election ResultsGlobeNewswire(Fri, Jun 14)
- QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Fri, Jun 14)
- QLT INC/BC Files SEC form 8-K/A, Financial Statements and ExhibitsEDGAR Online(Thu, May 23)
- QLTI July Options Begin Tradingat TheStreet(Mon, May 20)
- QLT Is Now Oversold (QLTI)at TheStreet(Fri, May 17)
- U.S. Steel Director Buys More Than 72K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, May 15)
- QLT INC/BC FinancialsEDGAR Online Financials(Fri, May 10)
- QLT Narrows LossZacks(Tue, May 7)
- QLT Director Buys 20K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Tue, May 7)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sat, May 4)
- QLT Earnings: Here’s Why Shares are Down Nowat Wall St. Cheat Sheet(Thu, May 2)
- QLT Inc. announce special cash distribution of $3.95 per sharetheflyonthewall.com(Thu, May 2)
- QLT Announces First Quarter 2013 ResultsGlobeNewswire(Thu, May 2)
- QLT INC/BC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, May 2)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.54 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.10 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 0.68 |
|---|
Business Summary
QLT Inc., a biotechnology company, engages in the development and commercialization of ocular products that address the unmet medical needs of patients and clinicians worldwide.
View More